Sucampo Pharma (Nasdaq: SCMP) and its development and commercialization partner, Takeda Pharmaceuticals (Takeda), announced the launch of a pilot direct-to-consumer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE